Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-29

Clinical Trial Update: Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating early growth hormone treatment in infants born small for gestational age to prevent irreversible neurologic and psycholog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Infant, Small for Gestational Age, Growth Hormone Treatment | Phase 2 | Status: UNKNOWN